BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22426846)

  • 1. Lack of interaction between sertraline and lamotrigine in psychiatric patients: a retrospective study.
    Christensen J; Sandgaard AP; Sidenius P; Linnet K; Licht RW
    Pharmacopsychiatry; 2012 May; 45(3):119-21. PubMed ID: 22426846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder.
    Schieber FC; Boulton DW; Balch AH; Croop R; Mallikaarjun S; Benson J; Carlson BX
    Hum Psychopharmacol; 2009 Mar; 24(2):145-52. PubMed ID: 19132712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracetamol decreases steady-state exposure to lamotrigine by induction of glucuronidation in healthy subjects.
    Gastrup S; Stage TB; Fruekilde PB; Damkier P
    Br J Clin Pharmacol; 2016 Apr; 81(4):735-41. PubMed ID: 26588196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lopinavir/ritonavir reduces lamotrigine plasma concentrations in healthy subjects.
    van der Lee MJ; Dawood L; ter Hofstede HJ; de Graaff-Teulen MJ; van Ewijk-Beneken Kolmer EW; Caliskan-Yassen N; Koopmans PP; Burger DM
    Clin Pharmacol Ther; 2006 Aug; 80(2):159-68. PubMed ID: 16890577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
    Sale ME; Natarajan S; Biton V; Vuong A; Hammer AE; Messenheimer JA; Blum D
    Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bidirectional interaction of valproate and lamotrigine in healthy subjects.
    Anderson GD; Yau MK; Gidal BE; Harris SJ; Levy RH; Lai AA; Wolf KB; Wargin WA; Dren AT
    Clin Pharmacol Ther; 1996 Aug; 60(2):145-56. PubMed ID: 8823232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between plasma concentrations of lamotrigine and its early therapeutic effect of lamotrigine augmentation therapy in treatment-resistant depressive disorder.
    Kagawa S; Mihara K; Nakamura A; Nemoto K; Suzuki T; Nagai G; Kondo T
    Ther Drug Monit; 2014 Dec; 36(6):730-3. PubMed ID: 24819973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine toxicity secondary to sertraline.
    Kaufman KR; Gerner R
    Seizure; 1998 Apr; 7(2):163-5. PubMed ID: 9627209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of an Optimal Dose of Lamotrigine for Augmentation Therapy in Treatment-Resistant Depressive Disorder From Plasma Lamotrigine Concentration at Week 2.
    Nakamura A; Mihara K; Nagai G; Kagawa S; Suzuki T; Nemoto K; Kondo T
    Ther Drug Monit; 2016 Jun; 38(3):379-82. PubMed ID: 26829597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of raltegravir on the glucuronidation of lamotrigine.
    van Luin M; Colbers A; Verwey-van Wissen CP; van Ewijk-Beneken-Kolmer EW; van der Kolk M; Hoitsma A; da Silva HG; Burger DM
    J Clin Pharmacol; 2009 Oct; 49(10):1220-7. PubMed ID: 19717722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine in children and adolescents: the impact of age on its serum concentrations and on the extent of drug interactions.
    Reimers A; Skogvoll E; Sund JK; Spigset O
    Eur J Clin Pharmacol; 2007 Jul; 63(7):687-92. PubMed ID: 17497143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic interaction study between eslicarbazepine acetate and lamotrigine in healthy subjects.
    Almeida L; Nunes T; Sicard E; Rocha JF; Falcão A; Brunet JS; Lefebvre M; Soares-da-Silva P
    Acta Neurol Scand; 2010 Apr; 121(4):257-64. PubMed ID: 20047572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioequivalence of generic lamotrigine 100-mg tablets in healthy Thai male volunteers: a randomized, single-dose, two-period, two-sequence crossover study.
    Srichaiya A; Longchoopol C; Oo-Puthinan S; Sayasathid J; Sripalakit P; Viyoch J
    Clin Ther; 2008 Oct; 30(10):1844-51. PubMed ID: 19014839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder.
    Kessing LV; Hellmund G; Andersen PK
    J Psychopharmacol; 2012 May; 26(5):644-52. PubMed ID: 21948935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of pharmacokinetic interaction between lamotrigine and olanzapine in healthy volunteers.
    Jann MW; Hon YY; Shamsi SA; Zheng J; Awad EA; Spratlin V
    Pharmacotherapy; 2006 May; 26(5):627-33. PubMed ID: 16637792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of therapeutic drug monitoring data for treatment of bipolar disorder with lamotrigine.
    Unholzer S; Haen E
    Pharmacopsychiatry; 2015 Sep; 48(6):211-4. PubMed ID: 26252722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antiepileptic drug comedication on lamotrigine clearance.
    Weintraub D; Buchsbaum R; Resor SR; Hirsch LJ
    Arch Neurol; 2005 Sep; 62(9):1432-6. PubMed ID: 16157751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium versus lamotrigine augmentation in treatment resistant unipolar depression: a randomized, open-label study.
    Schindler F; Anghelescu IG
    Int Clin Psychopharmacol; 2007 May; 22(3):179-82. PubMed ID: 17414745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained remission with lamotrigine augmentation or monotherapy in female resistant depressives with mixed cyclothymic-dysthymic temperament.
    Manning JS; Haykal RF; Connor PD; Cunningham PD; Jackson WC; Long S
    J Affect Disord; 2005 Feb; 84(2-3):259-66. PubMed ID: 15708424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of lamotrigine into breast milk.
    Page-Sharp M; Kristensen JH; Hackett LP; Beran RG; Rampono J; Hale TW; Kohan R; Ilett KF
    Ann Pharmacother; 2006; 40(7-8):1470-1. PubMed ID: 16868219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.